NABC+肿瘤标志物质量要求.pdf

Laboratory Medicine Practice Guidelines Use of Tumor Markers in Clinical Practice: Quality Requirements Edited by Catharine M. Sturgeon and Eleftherios Diamandis The National Academy of Clinical Biochemistry Presents LABORATORY MEDICINE PRACTICE GUIDELINES USE OF TUMOR MARKERS IN CLINICAL PRACTICE: QUALITY REQUIREMENTS EDITED BY Catharine M. Sturgeon Eleftherios P. Diamandis Catharine M. Sturgeon, PhD Lance A. Liotta, PhD Department of Clinical Biochemistry Center for Applied Proteomics and Molecular Royal Infirmary of Edinburgh Medicine, College of Sciences, Edinburgh, United Kingdom George Mason University, Manassas, VA Eleftherios P. Diamandis, PhD Emmanuel F. Petricoin, PhD Department of Pathology and Laboratory Medicine, Center for Applied Proteomics and Molecular Mount Sinai Hospital, and Department of Laboratory Medicine, College of Sciences, George Mason Medicine and Pathobiology, University of Toronto, University, Manassas, VA Toronto, Ontario, Canada Manfred Schmitt, PhD Barry R. Hoffman, PhD Clinical Research Unit, Department of Obstetrics and Department of Pathology and Laboratory Medicine, Gynecology, Technical University of Munich, Mount Sinai Hospital, and Department of Laboratory Munich, Germany Medi